- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Zydus Lifesciences Limited — Updates, 21-09-2025: Press Release
21-09-2025 | 08:48 am
21-09-2025 | 08:48 am
Zydus's oncology injectable facility in Ahmedabad received a USFDA Establishment Inspection Report classified as Voluntary Action Indicated (VAI). This significantly upgrades the facility's regulatory status from its prior Official Action Indicated (OAI) classification, improving operational outlook for US markets.
No comments yet. Be the first to comment!